14-day Premium Trial Subscription Sign Up For FreeGet Free

High volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35

StockInvest.us, 1 month ago

StockInvest.us

The Oncology Pharma Inc. stock price fell by -16.11% on the last day (Thursday, 16th Sep 2021) from $13.53 to $11.35. and has now fallen 4 days in a row. During the day the stock fluctuated 21.88% from a day low at $11.20 to a day high of $13.65. The price has fallen in 7 of the last 10 days and is down by -37.98% for this period. Volume has increased on the last day by 294 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 490 thousand shares were bought and sold for approximately $5.56 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -54.36% during the next 3 months and, with a 90% probability hold a price between $3.44 and $7.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Oncology Pharma Inc.

There are few to no technical positive signals at the moment. The Oncology Pharma Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.15 and $18.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, August 26, 2021, and so far it has fallen -44.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.45 between high and low, or 21.88%. For the last week, the stock has had a daily average volatility of 12.04%.

Oncology Pharma Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Oncology Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Check full Oncology Pharma Inc. forecast and analysis here.